Transl Androl Urol 2016-12-01
Invited commentary on GETUG-AFU 16.
Related Questions
Does the update of RTOG 96-01, presented at ASTRO 2015, change your practice for these patients? Or should ADT be limited to a particular subgroup?
New answer by Radiation Oncologist at Phoenix CyberKnife and Radiation Oncology Center (May 4, 2019)
I remain unconvinced that concurrent/adjuvant hormonal therapy increases the cure rate of salvage radiotherapy. I think hormonal therapy merely delays manifestation of r...
New answer by Radiation Oncologist at UPMC Hillman Cancer Center (October 30, 2020)
Certainly, this is an area of evolving management. Here’s what we know about the use of ADT in the salvage setting:
RTOG 9601: 2 years of bicalutamide improved 12y OS b...